首页/数据集/Anti-tumor activity of a novelLAIR1antagonist in combination with anti-PD-1to treat collagen-rich solid tumors

Anti-tumor activity of a novelLAIR1antagonist in combination with anti-PD-1to treat collagen-rich solid tumors

NIAID Data Ecosystem2026-05-02 收录

肿瘤免疫联合疗法

免疫检查点抑制剂联合治疗

数据链接：

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE260599 数据链接链接失效反馈

官方服务：

资源简介：

This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

应用场景：

创建时间：

2024-08-07

晚期子宫内膜癌治疗

免疫检查点抑制剂联合治疗

Objective: The objective of this meta-analysis was to conduct a comprehensive assessment of the therapeutic effectiveness and safety profile of the combination of immune checkpoint inhibitors (ICIs) w

DataCite Commons2024-10-28 更新60

Additional file 3 of Dual inhibition of HERs and PD-1 counteract resistance in KRASG12C-mutant head and neck cancer

KRAS突变头颈癌

肿瘤免疫联合疗法

Supplementary Material 3.

Figshare2024-11-21 更新30

Synergism of chemotherapy and PD-1 immune checkpoint blockade in the PyMT mammary carcinoma mouse model

肿瘤免疫联合疗法

全长转录组分析

We studied the impact of a combination of chemotherapy and PD-1 immune checkpoint blockade on tumor progression in the PyMT mammary carcinoma mouse model compared to each treatment as monotherapy. To

NIAID Data Ecosystem20

PPARd inhibition blocks tumor-induced Bregs and enhances CD40 agonist immunotherapy

肿瘤免疫联合疗法

细胞靶向治疗

Most cancers are cold tumors characterized by a lack of effector T cells and hence unresponsive to immune checkpoint blockades, highlighting the importance of repairing the failed T cell priming in ca

NIAID Data Ecosystem40

CSF1R inhibition plus chemotherapy induces systemic anti-tumor immune responses in triple negative breast cancer and sensitizes tumors to anti-PD-1 therapy by relieving resident memory T cell dysfunction [lymph node]

肿瘤免疫联合疗法

免疫细胞受体测序分析

Triple-negative breast cancer (TNBC) is a heterogeneous and aggressive disease where limited therapeutic options are available. A significant correlation exists between presence of intratumoral macrop

NIAID Data Ecosystem20

Anti-tumor activity of a novelLAIR1antagonist in combination with anti-PD-1to treat collagen-rich solid tumors

资源简介：

相关数据集